Company intelligence / Profile preview

PinkDx

Daly City, California, United Statespinkdx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

PinkDx is an early-stage company developing non-invasive diagnostic tests to improve the detection of gynecological cancers in women presenting with vague symptoms. The company leverages advanced bioinformatics and machine learning on diverse patient samples to create accurate, less invasive alternatives to current diagnostic procedures. No clinical results have been published as of June 2025.

Therapeutic areas: Oncology
Modalities: Diagnostic testBioinformatics-based diagnosticsMachine learning-based diagnostics
Industry: Molecular Diagnostics

Partnerships

Bakar Labs/University of California Berkeley incubator partnership via BEVC investment

Beyond the preview

Go deeper on PinkDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PinkDx.

Explore the full profile